FDA Grants Limited COVID Booster Vaccine Approval
Okay,here’s a summary of the key facts from the provided text,focusing on the changes to COVID-19 vaccine recommendations:
current FDA Restrictions (as of the article’s information):
Adults 65+: Still recommended to receive updated COVID shots.
Adults under 65 with underlying medical conditions: Recommended to receive updated COVID shots.
Healthy adults under 65: No longer broadly recommended.
Healthy Children: No longer broadly recommended; the FDA says vaccination decisions should be made through “shared clinical decision-making” between parents and pediatricians.
Pregnant Women: The CDC previously recommended vaccination, but in Spring 2025, Kennedy announced the CDC no longer recommends the COVID-19 vaccine for healthy pregnant women.Vaccine brand Age Ranges (for those with underlying conditions under 65):
pfizer-BioNTech (Comirnaty): ages 5 through 64 years
Moderna (Spikevax): Ages 6 months through 64 years
Novavax (Nuvaxovid): Ages 12 months through 64 years
Who is Considered High risk?
Older Adults: those over 65 are at the highest risk of severe illness.
Individuals with Chronic Conditions: Including cancer, kidney disease, liver disease, lung disease, cystic fibrosis, dementia, diabetes, disabilities, heart conditions, HIV, obesity, smoking, and a compromised immune system.
* Pregnant Women: Previously considered high risk, but current CDC recommendations have changed.
Critically important Note: The American Academy of Pediatrics still recommends COVID vaccination for young children (6-23 months), despite the shift in CDC guidance.
In essence, the FDA has significantly narrowed the recommendations for updated COVID-19 vaccines, focusing primarily on older adults and those with medical conditions that increase their risk of severe illness.